Pacira Pharmaceuticals, Inc. recalls EXPAREL (bupivacaine liposome injectable suspension), 1.3%, 266 mg/20 mL (13.3 mg/mL) single use vials, INVESTIGATIONAL
Recalled March 6, 2013 · FDA recall D-168-2013 · Pacira Pharmaceuticals
Hazard
Subpotent; bupivacaine · FDA Class II
Units
324 vials
Sold at
Nationwide distribution: AZ, DC, FL, GA, MA, NJ, NY, OH, and TX.
Description
Subpotent; bupivacaine
Product
EXPAREL (bupivacaine liposome injectable suspension), 1.3%, 266 mg/20 mL (13.3 mg/mL) single use vials, INVESTIGATIONAL USE. For Infiltration Only. Not for any other route of administration. Manufactured by Paelra Pharmaceuticals. Inc., San Diego, California, USA
Manufacturer(s)
Pacira Pharmaceuticals, Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →